The recommended regimen of Azasite is 1 drop twice daily for the first two days and then 1 drop once daily for the next five days.
Azasite During Pregnancy or Breastfeeding
There are no adequate studies of Azasite in pregnant women and it is not known whether Azasite is excreted in breast milk. Only use Azasite in pregnant or nursing mothers when absolutely necessary.
Additional Information
Our Azasite Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Azasite Consumer Information
Stop using this medicine and get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).
Call your doctor at once if you have:
drainage or crusting of your eye;
severe burning, stinging, itching, or other irritation after using the eye drops;
feeling like something is in your eye;
changes to the surface of your eye;
eye pain or swelling;
eyelid irritation; or
any signs of a new infection.
Common side effects may include:
eye irritation;
dry or itchy eyes;
blurred vision;
stuffy nose; or
changes in your sense of taste.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Because clinical trials are
conducted under widely varying conditions, adverse reaction rates observed in
one clinical trial of a drug cannot be directly compared with the rates in the
clinical trials of the same or another drug and may not reflect the rates
observed in practice.
The data described below
reflect exposure to AzaSite in 698 patients. The population was between 1 and
87 years old with clinical signs and symptoms of bacterial conjunctivitis. The
most frequently reported ocular adverse reaction reported in patients receiving
AzaSite was eye irritation. This reaction occurred in approximately 1-2% of
patients. Other adverse reactions associated with the use of AzaSite were
reported in less than 1% of patients and included ocular reactions (blurred
vision, burning, stinging and irritation upon instillation, contact dermatitis,
corneal erosion, dry eye, eye pain, itching, ocular discharge, punctate
keratitis, visual acuity reduction) and non-ocular reactions (dysgeusia, facial
swelling, hives, nasal congestion, periocular swelling, rash, sinusitis,
urticaria).
&Copy; Azasite Patient Information is supplied by Cerner Multum, Inc. and Azasite Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.
